Oxyphenonium (bromide) (Synonyms: (±)-Oxyphenonium) |
Catalog No.GC18332 |
Oxyphenonium is an antagonist of muscarinic acetylcholine receptors that binds to muscarinic receptors on isolated guinea pig atria and ileum (Kds = 0.11 and 0.17 nM, respectively).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1950/10/2
Sample solution is provided at 25 µL, 10mM.
Oxyphenonium is an antagonist of muscarinic acetylcholine receptors that binds to muscarinic receptors on isolated guinea pig atria and ileum (Kds = 0.11 and 0.17 nM, respectively). In vivo, oxyphenonium reverses carbaminocholine- and acetylcholine-induced decreases in blood pressure in anesthetized cats (ED50s = 0.591 and 1 μg/kg, respectively). It decreases rumenal ulcer formation in rats and suppresses insulin-induced gastric secretion in dogs with gastric fistulas. Oxyphenonium also prevents form-deprivation myopia (FDM) in a chick model of experimental myopia. Formulations containing oxyphenonium have been used to treat peptic ulcers.
Review for Oxyphenonium (bromide)
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)Review for Oxyphenonium (bromide)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *